Intrinsiqq
ProShares Ultra Nasdaq Biotechnology logo

ProShares Ultra Nasdaq Biotechnology

BIBETF · Nasdaq

$118.56

+$3.29 (+2.85%)

EOD Oct 28, 2026

Compare BIB with another ETF

Key facts

Expense ratio
0.95%
Dividend yield (TTM)
0.18%
Distributions
Quarterly
Fund net assets (Aug 2026)
$101M
Stocks held
250
Other positions
12
Turnover (last fiscal year)
29%
52-week range
$67.50 to $126.40

Top 10 holdings

All holdings

28.0% of assets in ten stocks, as of Aug 31, 2026

BIB top 10 holdings by weight
CompanyWeightQuality
IQProshares Genius Money Market EtfIQMM4.94%n/a
Amgen Inc.AMGN4.72%48
Vertex Pharmaceuticals IncorporatedVRTX4.50%47
Gilead Sciences Inc.GILD4.02%48
Regeneron Pharmaceuticals, Inc.REGN2.90%54
Moderna, Inc.MRNA1.96%20
Revolution Medicines Inc.RVMD1.54%10
Illumina, Inc.ILMN1.14%68
Alnylam Pharmaceuticals IncALNY1.13%81
Biogen Inc.BIIB1.13%39

Sector allocation

Share of the fund's assets

  • Healthcare50.6%
  • Industrials3.0%
  • Technology0.4%
  • Materials0.0%

Scores of what it owns

Every holding's score

Each holding's score, weighted by its size in the fund

42Qualityout of 10014Dividendout of 100

7% of the fund's stock weight sits in companies with a Quality score above 75, 63% in companies below 50.

Where it invests

Stock weight by the company's home country

  • United States51.5%
  • Netherlands1.3%
  • United Kingdom1.3%
  • Ireland0.9%
  • Bermuda0.9%
  • Denmark0.7%
  • Switzerland0.6%
  • France0.6%

And 9 more countries.

Growth of $10,000

With and without the dividends reinvested

BIB pays quarterly. Over the last twelve months it paid $0.22 per share, a 0.18% yield at today's price. The latest payment was $0.08, ex-dividend Sep 23, 2026.

Average annual returns

Total return at net asset value, to May 31, 2026, as reported to the SEC

BIB average annual total returns
1 year5 years10 years
98.53%0.58%6.51%

Past returns say nothing certain about future ones.

BIB questions

What does BIB invest in?+

ProShares Ultra Nasdaq Biotechnology is an exchange-traded fund. Its largest holdings are Proshares Genius Money Market Etf (4.94%), Amgen Inc. (4.72%), Vertex Pharmaceuticals Incorporated (4.50%).

What is BIB's expense ratio?+

0.95% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $95.00 a year.

How much does BIB pay in dividends?+

BIB paid $0.22 per share over the last twelve months, a 0.18% yield at the Oct 28, 2026 close of $118.56. It pays quarterly.

How good are the companies BIB owns?+

Weighted by position size, the stocks in BIB average a Quality score of 42 out of 100. 7% of the fund's stock weight sits in companies scoring above 75, 63% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.

More on BIB: Holdings · Dividend history

Holdings: the fund's latest SEC Form N-PORT, as of Aug 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to May 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 28, 2026.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.